Genus Caralluma in Yemen: A Comprehensive Review of Taxonomy, Ethnomedicine, Phytochemistry, and Biological Activities
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202501112 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Ola E Abdel-Sattar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Herbal Department, Egyptian Drug Authority, Giza, Egypt. Hauptthemen laut MEDLINE: Phytochemicals, Apocynaceae, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 210 Literaturangaben.
Abstract (Originalsprache)
This review provides up‐to‐date and comprehensive information on Caralluma species native to Yemen, linking traditional uses, taxonomy, phytochemistry, biological activities, and toxicology to guide future research. From over 300 scientific database sources, it identifies approximately 25 Caralluma species across Yemen's diverse landscapes, many endemics, with species like Caralluma dolichocarpa , Caralluma chrysostephana , and Caralluma eremastrum classified as endangered. In Yemen and other Asian regions, Caralluma is traditionally used to manage diabetes, gastrointestinal disorders, inflammation, leprosy, obesity, and arthritis. Key phytochemicals, including pregnane‐type steroidal aglycones and glycosides, flavone glycosides, megastigmane glycosides, and triterpenes, which support its medicinal properties. in addition to flavone glycosides, megastigmane glycosides, bitter principles, and triterpenes. Pharmacological studies of Yemeni Caralluma extracts and isolated compounds demonstrated notable antibacterial, antioxidant, anticancer, and antidiabetic, and anti‐inflammatory activities in both in vitro and in vivo models. These biological activities could be attributed to the occurrence of specific chemical classes in Caralluma genus. The review highlights the urgent need for further research on the conservation of endemic species and for the scientific validation of traditional uses, positioning Caralluma as a valuable resource for future drug discovery and ethnopharmacological studies in Yemen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Herbal Department, Egyptian Drug Authority, Giza, Egypt.
- Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Biology, Faculty of Science, University of Aden, Aden, Yemen.
ORCID-Profile: Essam Abdel-Sattar
Zitieren
APA
Abdel-Sattar, O. E., Sabry, M. M., Shalabi, A. A., El-Halawany, A. M., Al-Hawshabi, O. S. S., Abdel-Sattar, E., Meselhy, M. R., & El-Shiekh, R. A. (2025). Genus Caralluma in Yemen: A Comprehensive Review of Taxonomy, Ethnomedicine, Phytochemistry, and Biological Activities. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501112
Vancouver
Abdel-Sattar OE, Sabry MM, Shalabi AA, El-Halawany AM, Al-Hawshabi OSS, Abdel-Sattar E, et al. Genus Caralluma in Yemen: A Comprehensive Review of Taxonomy, Ethnomedicine, Phytochemistry, and Biological Activities. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501112
BibTeX
@article{AbdelSattar2025,
author = {Abdel-Sattar, Ola E and Sabry, Manal M and Shalabi, Akram A and El-Halawany, Ali M and Al-Hawshabi, Othman S S and Abdel-Sattar, Essam and Meselhy, Meselhy R and El-Shiekh, Riham A},
title = {Genus Caralluma in Yemen: A Comprehensive Review of Taxonomy, Ethnomedicine, Phytochemistry, and Biological Activities},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202501112}
}
EUVIMED